Avacta Affimer News Today

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATIONS NO. 596/2014 AS IT FORMS...

Life sciences company Avacta has announced a second milestone equity payment increasing its shareholding in AffyXell Therapeutics, a joint venture to develop next-generation cell therapies between Avacta and Daewoong Pharmaceutical in South Korea. Click to read more...

Avacta Group PLC on Monday celebrated rapid progress on its joint venture in South Korea, following a second equity payment. The Wetherby, England-based life sciences company said that the payment... | June 5, 2023

Wetherby-based life sciences company Avacta Group has made “rapid progress” with a joint venture project in Southy Korea to develop next-generation cell therapies.

Life science company Avacta Group announced on Monday that a second milestone equity payment had been triggered, resulting in an increased shareholding for Avacta in AffyXell Therapeutics.

LG Chem will now proceed with Investigational New Drug (IND) enabling studies for Affimer PD-L1 antagonist programme Avacta Group plc (AIM: AVCT), a clinical stage biopharmaceutical company developing

Avacta Group plc (AIM: AVCT), a clinical stage oncology drug company and developer of powerful diagnostics based on its innovative Affimer and pre|CISION platforms, is pleased to announce that a milestone

Investegate announcements from Abingdon Health PLC, Update on AffiDX� SARS-CoV-2 antigen LFT

Clinical stage biopharmaceutical Avacta Group has announced achievement of a pre-clinical milestone in its multi-target therapeutics development partnership (ILM No, 2020) with LG Chem Life Sciences, the life sciences division of the South Korean LG Group, resulting in an undisclosed milestone payment. Click to read more...

SMALL CAP MOVERS: Avacta shares soar as test detects new Covid variant; Premier African on a lithium charge John Harrington, Proactive Investors For Thisismoney.co.uk © Provided by This Is Money MailOnline logo Premier African Metals continued its astonishing rise this week after it was formally granted an exclusive prospect order in Zimbabwe. The EPO covers the Zulu Lithium and Tantalum claims. The company’s chief executive, George Roach, highlighted that the EPO area cont...